Chemoinformaics analysis of 3,7,11,15-Tetramethylhexadec-2-En-1-Ol
| Molecular Weight | 296.539 | nRot | 13 |
| Heavy Atom Molecular Weight | 256.219 | nRig | 1 |
| Exact Molecular Weight | 296.308 | nRing | 0 |
| Solubility: LogS | -6.641 | nHRing | 0 |
| Solubility: LogP | 7.764 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 61 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 21 | No. of Aromatic Carbocycles | 0 |
| nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 40 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 20 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
| nHA | 1 | APOL | 60.8737 |
| nHD | 1 | BPOL | 40.1283 |
| QED | 0.392 |
| Synth | 3.291 |
| Natural Product Likeliness | 1.532 |
| NR-PPAR-gamma | 0.006 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.034 |
| Pgp-sub | 0.001 |
| HIA | 0.002 |
| CACO-2 | -4.338 |
| MDCK | 0.0000107 |
| BBB | 0.227 |
| PPB | 0.976409 |
| VDSS | 3.722 |
| FU | 0.0240023 |
| CYP1A2-inh | 0.401 |
| CYP1A2-sub | 0.18 |
| CYP2c19-inh | 0.314 |
| CYP2c19-sub | 0.11 |
| CYP2c9-inh | 0.464 |
| CYP2c9-sub | 0.951 |
| CYP2d6-inh | 0.053 |
| CYP2d6-sub | 0.038 |
| CYP3a4-inh | 0.164 |
| CYP3a4-sub | 0.119 |
| CL | 8.161 |
| T12 | 0.073 |
| hERG | 0.013 |
| Ames | 0.002 |
| ROA | 0.008 |
| SkinSen | 0.96 |
| Carcinogencity | 0.106 |
| EI | 0.951 |
| Respiratory | 0.059 |
| NR-Aromatase | 0.01 |
| Antiviral | Yes |
| Prediction | 0.509146 |